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Abstract
Background: The immature granulocyte count has been reported to be a marker of infection and sepsis. The
difference in leukocyte subfractions (delta neutrophil index, DNI) in ADVIA 2120 reflects the fraction of circulating
immature granulocytes in the blood. This study evaluated the clinical utility of DNI as a severity and prediction
marker in critically ill patients with sepsis.
Methods: One hundred and three patients admitted to the medical intensive care unit with sepsis were studied.
DNI (the difference in leukocyte subfractions identified by myeloperoxidase and nuclear lobularity channels) was
determined using a specific blood cell analyzer.
Results: Forty four patients (42.7%) were diagnosed with severe sepsis/septic shock. Overt disseminated
intravascular coagulation (DIC) occurred in 40 (38.8%). DNI was significantly higher in patients with severe sepsis/
septic shock and overt DIC than in patients without (p < 0.05). DNI correlated with DIC score (r = 0.54, p < 0.001).
We observed a monotonic increase in the proportion of overt DIC and severe sepsis/septic shock associated with
increasing quartiles of DNI (p < 0.001). A DNI value > 6.5% was a better indicator of severe sepsis/septic shock than
C-reactive protein, lactate, white blood cell count, and absolute neutrophil count (sensitivity, 81.3%; specificity,
91.0%; positive predictive value, 88.6%; and negative predictive value, 84.7%). In 36 (82%) of the 44 patients with
severe sepsis/septic shock, DNI values were already elevated up to 12 hours before the onset of organ/circulatory
failure.
Conclusions: DNI may be used as a marker of disease severity in critically ill patients with sepsis. High levels of
DNI may help to identify patients with an impending risk of developing severe sepsis/septic shock.
Background
Sepsis is the leading cause of death in intensive care
units (ICUs) today. In spite of recent advances in anti-
biotic therapy and general critical care practices, includ-
ing early goal-directed treatment for septic shock [1],
mortality of patients with severe sepsis/septic shock is
still substantial [2,3]. Early diagnosis of infection and
sepsis before it progresses to organ dysfunction or circu-
latory failure has crucial impact on the clinical course
and outcome of critically ill patients [4]. However,
because sepsis is not a final diagnosis, but a clinical syn-
drome encompassing many heterogeneous conditions
with regard to etiology, infection focus, and even
presence of infection, there is no gold standard for the
detection of sepsis [5].
Many investigators have endeavored to find reliable
biomarkers which are useful for the diagnosis and man-
agement of sepsis. Ideally, the biomarker should reflect
not only the presence of sepsis, but also its severity.
Although several biomarkers have been investigated to
diagnose infection or sepsis [6,7], no single biologic
marker has been shown to reliably identify patients who
are at risk of developing severe sepsis or septic shock
[8], and tests for these markers are often not widely
available at the bedside.
During stress or infection, less mature neutrophil
forms enter circulation, including an increased number
of bands. This is referred to as a left-shift,w h i c hi s
defined as an elevated immature/total granulocyte ratio
or an elevated neutrophil band count [9]. The presence
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neutrophils is still used as a marker of infection or sep-
sis in clinical practice. Previous studies have demon-
strated the clinical usefulness of immature granulocytes
or the changes in leukocytes for predicting infection.
Granulocyte precursors less mature than bands were
reported to be a better predictor of infection than the
band counts [10]. Seebach et al. demonstrated a high
sensitivity (80%) of morphologic changes in neutrophils,
including toxic granulation, Döhle bodies, and cytoplas-
mic vacuoles, in predicting infection [11]. In a study by
Selig et al., myeloid progenitor cells were significantly
higher in infectious conditions [12]. Immature granulo-
cyte counts have also been reported as an indicator of
sepsis [13,14]. Therefore, the proportion of immature
granulocytes may be a better indicator of sepsis than
WBC, ANC, or even band neutrophils. However, these
granulocyte parameters are difficult to measure accu-
rately and their diagnostic value remains controversial
[9]. Consequently, a more reliable and reproducible
method to measure immature granulocytes might be
useful.
Recent technological advances have led to specific
modern automated cell analyzers that can provide infor-
mation on leukocyte differentials based on cytochemical
myeloperoxidase (MPO) reaction and nuclear lobularity
of the white blood cells [15-17]. Delta neutrophil index
(DNI), the difference between the leukocyte differentials
measured in the MPO channel and those assayed in the
nuclear lobularity channel, reflects the fraction of circu-
lating immature granulocytes. DNI has been reported to
be significantly associated with disseminated intravascu-
lar coagulation (DIC) scores, positive blood culture rate,
and mortality in patients with suspected sepsis [18]. The
data, however, are limited and little is known about the
clinical usefulness of DNI in evaluating sepsis severity
and in assessing risk of severe sepsis/septic shock in the
ICU setting.
In the present study, we investigated DNI values in
medical ICU patients with sepsis and evaluated the clini-
cal utility of DNI as an indicator of sepsis severity and
as a prediction marker of severe sepsis/septic shock.
Methods
Study population
This study was performed in the 30-bed medical ICU of
Severance Hospital in Seoul, Korea. The protocol was
approved by the Institutional Review Board, and written
informed consent was obtained from the patients or
next of kin.
Over a period of 6 months (from July 2010 to Decem-
ber 2010), all consecutive patients with clinically diag-
nosed sepsis at the time of ICU admission were
included. Systemic inflammatory response syndrome
(SIRS) was defined as two or more of the following con-
ditions: (a) body temperature > 38°C or < 36°C; (b) leu-
kocytosis (> 10,000/μl), leukopenia (< 4,000/μl), or >
10% bands; (c) heart rate > 90 beats/min; and (d)
respiratory rate > 24 breaths/min. Sepsis was defined as
SIRS with proven or suspected microbial etiology.
Severe sepsis was defined as sepsis plus sepsis-induced
organ dysfunction or tissue hypoperfusion. Septic shock
was defined as an acute circulatory failure characterized
by persistent arterial hypotension (systolic arterial pres-
sure below 90 mmHg, mean arterial pressure < 60
mmHg, or a reduction in systolic pressure of > 40
mmHg from baseline despite adequate fluid resuscita-
tion in the absence of other causes of hypotension) [19].
Exclusion criteria were age less than 18 years, preg-
nancy, patients with hematologic abnormalities, and
those who received granulocyte colony stimulating fac-
tors, glucocorticoid, or other immunosuppressants
before study enrollment.
Patients originated either from the emergency room or
from the general wards. At the time of notification for
ICU admission of each patient, every effort was made to
identify patients with suspected sepsis by dedicated
research fellows and attending physicians. Microbiologi-
cal tests were performed on blood samples, sputum (by
nasopharyngeal swab or endotracheal suction), urine
specimens, removed catheters, and secretions from
other body regions which were suspected to be the
infection source. All patients underwent chest radiogra-
phy and/or high resolution computed tomography scan,
magnetic resonance imaging scan, or endoscopy when
indicated by attending physicians without interference
by the study investigators. On the basis of laboratory,
bacteriological, and radiographic findings, “confirmed
infection” was determined by a definite source of infec-
tion (microbiology confirmed and/or positive culture at
a likely focus), and “probable infection” was determined
by positive imaging findings, such as an infiltration, cav-
ity, or abscess confirmed by specialized radiologists.
Thus, clinically diagnosed sepsis was defined by either
confirmed infection or probable infection under the pre-
sence of SIRS. During ICU stay, all patients were treated
following the international guidelines for management
of severe sepsis and septic shock [20].
Data collection
Baseline demographic data and clinical variables, includ-
i n ga g e ,s e x ,b l o o dp r e s s u r e ,p u l s er a t e ,p r i m a r ys i t eo f
infection, blood culture results, presence of severe sep-
sis/septic shock or overt DIC, average amount of norepi-
nephrine infusion, urine output during the first 24 hours
after ICU admission, and hospital mortality were
recorded. The presence or absence of mechanical venti-
lation and renal replacement therapy were also recorded.
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Sequential Organ Failure Assessment (SOFA) score [23]
were calculated on ICU admission to measure the sever-
ity of patient condition. Overt DIC was defined as DIC
score ≥ 5b a s e do nt h ed i a g n o s t i cc r i t e r i ab yt h eI n t e r -
national Society of Thrombosis and Hemostasis [24].
DNI and other blood sample measurements
Blood samples for the analyses of DNI and other labora-
tory parameters were obtained from indwelling arterial
catheters or by venipuncture within the first 24 hours of
I C Ua d m i s s i o n .T h eb l o o ds a m p l e sw e r ed r a w nf r o m
each patient into EDTA tube, and were immediately
transported at room temperature to the chemical
laboratory department, and the assay was performed
within 1 hour of blood sampling.
A specific type of automatic cell analyzer (ADVIA
2120 Hematology System, Siemens Healthcare Diagnos-
tics, Forchheim, Germany) was used for calculating
DNI. This is a flow cytometry-based hematologic analy-
zer which has two independent white blood cell (WBC)
analysis methods, an MPO channel and lobularity/
nuclear density channel. First, after lysis of red blood
cells (RBCs), the tungsten-halogen based optical system
of the MPO channel measures cell size by forward light
scatter, and stain intensity by absorbance, thereby
counting and differentiating granulocytes, lymphocytes,
and monocytes based on their size and MPO content.
Second, the laser diode-based optical system of the
lobularity/nuclear density channel counts and classifies
cells according to size, lobularity, and nuclear density
[17,18]. The formula for calculating DNI is as follows:
DNI = [the neutrophil subfraction and the eosinophil
subfraction measured in the MPO channel by cytochem-
ical MPO reaction] - [the PMN subfraction measured in
the nuclear lobularity channel by the reflected light
beam]. The correlation between DNI values and imma-
ture granulocytes by manual counting was reported in a
previous study [18]. The measurement of immature
granulocytes included promyelocytes, myelocyte, and
metamyelocytes, but not blasts.
Complete blood cell counts, including WBC count
and absolute neutrophil count (ANC), were measured
with an automated analyzer (ADVIA 2120 Hematology
System). Prothrombin time (PT), activated partial
thromboplastin time (aPTT), D-dimer, and fibrinogen
levels were assayed using an STA analyzer (Diagnostica
Stago, Asnieres-Sur-Seine, France). Antithrombin III
activity was determined using an ELISA kit (Diagnostica
Stago). Plasma C-reactive protein (CRP) concentration
was measured by direct immunoturbidimetry (CA400,
Beckman Coulter, CA, USA). Lactate levels were mea-
sured in arterial blood using point-of-care blood gas
analyzers (Critical Care Xpress, NOVA biomedical, MA,
USA). All measurements were performed according to
the manufacturers’ instructions.
Statistical analysis
Continuous variables are presented as the mean ± stan-
dard deviation (SD), or when the assumption of normal-
ity was violated, as median values and interquartile
range. Categorical variables were expressed as absolute
and relative frequencies. Comparisons between groups
were performed with chi-squared tests for categorical
variables and Mann-Whitney U test or Kruskal-Wallis
test for continuous variables, as appropriate. We classi-
fied patients according to the severity of sepsis (sepsis,
severe sepsis, and septic shock), and compared the
values of DNI and other laboratory biomarkers among
the groups. If statistically significant, post-hoc analysis
was performed using the Dunn procedure. For compari-
son, we presented the value of DNI in healthy subjects
as controls. The correlation between DNI and other
laboratory variables or clinical severity scores was tested
by Spearman’s method. The effect of increasing quartiles
of DNI on the proportion of overt DIC or severe sepsis/
septic shock was evaluated by the Cochrane-Armitage
trend test. Receiver-operating characteristics (ROC)
curves were constructed and the Youden Index method
was used to determine the optimal cut-off values for
DNI, WBC, ANC, lactate, and CRP for predicting severe
sepsis/septic shock. The areas under the curves (AUCs)
were calculated to compare the diagnostic performance
of each marker. A p-value of less than 0.05 was consid-
ered statistically significant. Statistical analyses were per-
formed using SAS software, version 9.2 (SAS Institute
Incorporated, Cary, NC, USA).
Results
Baseline clinical characteristics
A total of 103 patients admitted to ICU were enrolled.
Baseline clinical characteristics of the study participants
at enrollment are shown in Table 1. Forty-four (42.7%)
of 103 patients were diagnosed with severe sepsis/septic
shock. Overt DIC occurred in 40 (38.8%) of 103 patients
and microorganisms were isolated in 50 (48.5%) of 103
patients. Severe sepsis/sep t i cs h o c k ,o v e r tD I C ,u s eo f
renal replacement therapy, and higher SAPS 3 or SOFA
scores were more frequent in nonsurvivors compared to
survivors (p < 0.05).
DNI and other laboratory markers in different subgroups
of patients
DNI values were significantly higher in patients with
severe sepsis/septic shock (16.1 [7.7-34.2]% vs. 2.3 [0.2-
3.9]%; p < 0.001) and overt DIC (10.8 [4.7-17.4]% vs. 2.6
[0.8-6.7]%; p <0 . 0 0 1 )t h a ni np a t i e n t sw i t h o u ts e v e r e
sepsis/septic shock and overt DIC, respectively. Plasma
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groups. In contrast, there was considerable overlap in
WBC, ANC, and CRP levels between the groups (Table
2).
DNI and other markers in SIRS, sepsis, and severe sepsis/
septic shock group
When patients were classified into subgroups according
to the severity of sepsis (control group: n = 30, sepsis
group: n = 59, severe sepsis/septic shock group: n = 44),
DNI values increased according to disease severity from
the control group to severe sepsis/septic shock group. In
detail, median values and interquartile range of DNI
were 0 (0-0.1)% in the healthy control group, 2.8 (0.5-
5.3)% in the sepsis group, and 16.9 (9.5-35.6)% in the
severe sepsis/septic shock group (Figure 1). Similar
trend was also shown in lactate levels (median values of
0.9, 1.4, and 4.1 mmol/L). In contrast, significant incre-
mental trend was not observed in WBC (median values
of 7360, 13610, and 12970/mm
3), ANC (median values
of 4515, 9720, and 11665/mm
3), or CRP (median values
of 1.4, 16.1, and 15.7 mg/dL).
Relationship between DNI and laboratory variables/
clinical severity scores
DNI correlated positively with clinical severity scores;
SAPS 3 score (r = 0.31, p = 0.001), SOFA score (r =
0.34, p < 0.001), and DIC score (r = 0.54, p < 0.001; Fig-
ure 2). DNI did not correlate with WBC count (r =
0.07, p = 0.467) or ANC (r = 0.13, p = 0.184).
Proportion of overt DIC and severe sepsis/septic shock
according to the quartiles of DNI values
As shown in Figure 3, a monotonic increase in the pro-
portion of patients with overt DIC and severe sepsis/
septic shock was observed in association with increasing
quartiles of DNI values (p <0 . 0 0 1 ) .T h ef i r s t ,s e c o n d ,
and third quartile values of DNI values were 1.6, 4.3,
and 15.5%, respectively.
Performance of DNI and other laboratory markers in
identifying severe sepsis/septic shock
A cut-off value of 6.5% for DNI exceeded those for any
other laboratory markers for differentiating the presence
and absence of severe sepsis/septic shock (Table 3). As
shown in Figure 4, ROC curves demonstrated that DNI
was the best indicator of severe sepsis/septic shock, with
an AUC of 0.92 (95% confidence interval [CI], 0.86-
0.98). The accuracy of DNI for differentiating between
the presence and absence of severe sepsis/septic shock
was higher than those of other laboratory markers (p <
0.001 for DNI vs. WBC; p = 0.002 for DNI vs. ANC; p
= 0.02 for DNI vs. lactate; and p = 0.009 for DNI vs.
CRP).
Time course of DNI values before and after the onset of
severe sepsis/septic shock
Although we enrolled patients in a consecutive manner,
we could also check the DNI values of them up to 12
hours before the onset of organ dysfunction or signifi-
cant hypotension (retrospective data collection before
ICU admission). Using the cut-off levels in Table 3 DNI
values already increased before the onset of organ/circu-
latory failure in 36 (82%) of the 44 patients with severe
sepsis/septic shock, and decreased over time after ICU
admission (p < 0.001). This evolutionary pattern was not
observed in WBC (p =0.235) or ANC (p = 0.223; Figure
5).
Table 1 Baseline clinical characteristics of patients by
survival
Variables Survivors
(n = 56)
Nonsurvivors
(n = 47)
p
Age 62.6 ± 17.5 69.4 ± 12.4 0.081
Gender (male) 35 (62.5%) 33 (70.2%) 0.410
Primary site of
infection
Lung 26 (46.4%) 30 (63.8%)
Intra-abdomen 13 (23.2%) 11 (23.4%)
Genitourinary 13 (23.2%) 6 (12.8%)
Skin and soft
tissue
3 (5.4%) 0 (0%)
Others 1 (1.8%) 0 (0%)
Severe sepsis/septic
shock
17 (30.4%) 27 (57.4%) 0.005
Overt DIC 12 (21.4%) 28 (59.6%) < 0.001
Positive blood
culture
24 (42.8%) 26 (55.3%) 0.305
Gram positive 6 (10.7%) 4 (8.5%)
Gram negative 10 (17.8%) 18 (38.3%)
Fungus 8 (14.3%) 4 (8.5%)
None detected 32 (57.2%) 21 (44.7%)
SAPS 3 62.8 ± 13.6 76.5 ± 14.8 < 0.001
SOFA score 7.9 ± 4.2 11.7 ± 4.8 < 0.001
Mechanical
ventilation
31 (55.4%) 29 (61.7%) 0.564
Renal replacement
therapy
12 (21.4%) 24 (51.1%) 0.002
Norepinephrine
infusion
1.4 ± 3.1 0.7 ± 1.3 0.107
Urine output (24
hours)
2640.7 ±
1461.6
2543.9 ± 1434.6 0.791
Continuous variables are presented as the mean ± standard deviation.
Categorical variables are expressed as absolute and relative frequencies within
each column.
DIC, disseminated intravascular coagulation; SAPS, Simplified Acute Physiology
Score; SOFA, Sequential Organ Failure Assessment; Norepinephrine infusion,
average amount of norepinephrine infusion per hour during the first 24 hours
in the intensive care unit (ICU); Urine output, total amount of urine output
during the first 24 hours in the ICU.
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In this study, we demonstrated that DNI, which reflects
the number of circulating granulocyte precursors in the
blood, correlated with the severity of sepsis in critically
ill patients admitted to the medical ICU. The elevation
of DNI value preceded the onset of organ/circulatory
failure, thus contributing to identifying patients with an
impending risk of developing severe sepsis/septic shock.
In the present study, increased DNI values at the time
of ICU admission were significantly associated with the
presence of severe sepsis/septic shock and overt DIC.
These results are consistent with a previous report by
Table 2 Delta neutrophil index and other laboratory markers in different subgroups of patients
Variables Without severe sepsis/septic shock
(n = 59)
Severe sepsis/septic shock
(n = 44)
WBC, 10
3/uL 11610 (8940-19210) 13820 (8870-21505) 0.655
ANC, 10
3/uL 10100 (6230-14440) 11805 (7103-19238) 0.394
DNI, % 2.3 (0.2-3.9) 16.1 (7.7-34.2) < 0.001
Lactate, mmol/L 1.8 (1.2-3.65) 4.0 (2.1-9.9) < 0.001
CRP, mg/dL 11.3 (4.6-19.2) 16.2 (9.8-28.3) 0.017
Without overt DIC
(n = 63)
Overt DIC
(n = 40)
WBC, 10
3/uL 12780 (9230-20180) 11805 (8150-22320) 0.768
ANC, 10
3/uL 10780 (6870-16890) 9765 (4775-17438) 0.629
DNI, % 2.6 (0.8-6.7) 10.8 (4.7-17.4) < 0.001
Lactate, mmol/L 1.9 (1.2-3.5) 4.7 (2.4-14.2) < 0.001
CRP, mg/dL 13.6 (5.4-24.3) 15.1 (2.8-23.3) 0.854
Data are expressed as median (interquartile range).
WBC, white blood cell count; ANC, absolute neutrophil count; DNI, delta neutrophil index; CRP, C-reactive protein
Healthy 
controls
Sepsis Severe sepsis/
septic shock
p = 0.003
p < 0.001
Figure 1 Delta neutrophil index (DNI) values in subgroups with
different sepsis severity. Box plots represent the 25
th and 75
th
percentiles, with the internal horizontal lines showing the median.
DNI values increased with disease severity from the control group
to the severe sepsis/septic shock group.
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Figure 2 Correlation of delta neutrophil index with clinical
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Sequential Organ Failure Assessment; DIC, disseminated intravascular
coagulation.
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Page 5 of 9Nahm et al. who concluded that DNI was closely related
to the presence of overt DIC, bacterial isolation rate,
and mortality in patients with suspected sepsis [18]. In
another study by Ansari-Lari et al., the percentage of
immature granulocytes correlated better with infection
and positive blood culture results than the WBC count
[13], but the sensitivity was low (40% sensitivity at 90%
specificity). Consequently, the authors suggested that
high cut-off levels for the percentage of immature gran-
ulocytes might be required to reliably predict infection
or positive blood culture results. In that study, however,
the authors tested the usefulness of immature granulo-
cytes as a predictor of infection, not sepsis. In contrast,
we evaluated the clinical usefulness of DNI in sepsis
(including severe sepsis/septic shock). These different
inclusion criteria may have yielded different sensitivity,
specificity, and even higher optimal cut-off value for
DNI in our results.
Severe forms of sepsis are associated with DIC, and
DIC is often present before the onset of sepsis [25]. We
found that DNI correlated with SAPS 3, SOFA, and DIC
score. Similar to our results, a previous report by Nahm
et al. also demonstrated a significant relationship
between DNI and DIC-related parameters, including
platelet count, PT, aPTT, and antithrombin III [18].
These findings suggest that DNI may be linked to a
hypercoagulable state which is associated with sepsis,
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Figure 3 Proportion of overt disseminated intravascular
coagulation (DIC) and severe sepsis/septic shock according to
the quartiles of delta neutrophil index (DNI) values. The first,
second, and third quartile values of DNI values were 1.6, 4.3, and
15.5%, respectively. The proportion of patients with overt DIC and
severe sepsis/septic shock increased in association with increasing
quartiles of DNI values (p < 0.001). p-values were derived from the
Cochrane-Armitage trend test.
Table 3 Performance of delta neutrophil index and other laboratory markers in differentiating between the presence
and absence of severe sepsis/septic shock
Variables Cut-off level Sensitivity
(%)
Specificity
(%)
Positive predictive value (%) Negative predictive value (%)
DNI 6.5% 81.3% 91% 88.6% 84.7%
WBC 16590/mm
3 45.8% 69.1% 56.4% 59.4%
ANC 14100/mm
3 45.8% 72.7% 59.4% 60.6%
Lactate 2.1 mmol/L 76.7% 57.1% 61.1% 73.7%
CRP 15.4 mg/dL 59.6% 66% 62.2% 63.5%
DNI, delta neutrophil index; WBC, white blood cell count; ANC, absolute neutrophil count; CRP, C-reactive protein.
Source of the curve
Delta neutrophil index
WBC
ANC
C-reactive protein
Lactate
Reference line
Figure 4 Receiver operating characteristics (ROC) curves of
delta neutrophil index (DNI) and other laboratory markers for
differentiating between the presence and absence of severe
sepsis/septic shock. Areas under ROC were 0.92 (95% CI, 0.86-0.98)
for DNI, 0.53 (95% CI, 0.41-0.64) for white blood cell (WBC), 0.76
(95% CI, 0.61-0.82) for lactate, and 0.64 (95% CI, 0.53-0.75) for C-
reactive protein (CRP). The accuracy of DNI for discriminating
between the presence and absence of severe sepsis/septic shock
was superior to those of other laboratory markers (p < 0.05).
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cally ill patients with sepsis.
In our results, DNI values were higher in the severe
sepsis/septic shock group compared to the sepsis group.
In line with this finding, the Cochrane-Armitage trend
test also showed that the proportion of patients with
overt DIC and severe sepsis/septic shock gradually
increased with the increase in DNI values. Importantly,
the proportion abruptly increased when DNI was higher
than 4.3% (the second quartile value of DNI). In our
ROC analysis, the diagnostic value of DNI for severe
sepsis/septic shock was superior to WBC, ANC, or
other widely available laboratory markers. The optimal
cut-off value of DNI for predicting severe sepsis/septic
shock was 6.5%. Taken together, our data suggest that
careful attention may be required in patients with sus-
pected infection for possible concomitant DIC and/or
severe sepsis/septic shock if DNI value increases up to
4-6% or more.
A recent study showed that mortality was correlated
to the duration of hypotension before the start of anti-
biotic treatment [4]. Therefore, it is very important role
for clinicians to identify patients who are at risk of
developing severe sepsis/septic shock before the signs of
organ dysfunction or circulatory failure appear. In the
present study, DNI values had already increased before
the onset of organ/circulatory failure in 82% of the
patients with severe sepsis/septic shock, suggesting that
DNI may help to identify patients with an imminent
risk of developing severe sepsis/septic shock. Given that
the process of granular leukocyte differentiation starts
from immature granulocyte formation, the change in
DNI may have preceded the change in absolute numbers
of WBC or neutrophil, thus contributing to predicting
the development of severe sepsis/septic shock. Based on
our data, we suggest that the finding of an increased
DNI value should alert clinicians to start fluid resuscita-
tion or to change antibiotic treatment.
Several limitations of our study should be mentioned.
First, this was a single-center study and the sample
size was relatively small. Second, the elevation of
immature granulocytes is not specific for infection and
may be observed in various other conditions, including
myeloproliferative disorders, chronic inflammatory dis-
eases, tissue damage, acute hemorrhage, and neoplasia
[9]. Because DNI is also one of the leukocyte-related
parameters, there may be a lack of sensitivity or speci-
ficity for DNI as a severity marker of sepsis in this
group. Third, we did not evaluate the comparative
advantage of using DNI over procalcitonin which may
h a v ear o l ei nr e d u c i n ga n t i b i o t i ce x p o s u r eo fc r i t i c a l l y
ill patients [26] and serve as a useful complementary
comparator for prediction of survival outcome in post-
operative patients with severe sepsis [27]. Because the
p = 0.003
p = 0.005
Figure 5 Time course of delta neutrophil index (DNI) values,
white blood cell (WBC) counts, and absolute neutrophil counts
(ANC) before and after the onset of severe sepsis/septic shock.
On the basis of the optimal cut-off values (DNI, 6.5%; WBC, 16590/
mm
3; and ANC, 14100/mm
3) presented in Table 3, DNI values
already elevated before the onset of organ/circulatory failure in 36
(82%) of the 44 patients with severe sepsis/septic shock, and
decreased over time after ICU admission (p < 0.001). In contrast,
there were no changes in WBC counts (p =0.235) or ANC (p =
0.223) over time.
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Page 7 of 9main focus of the present study was DNI, and the
decision to check procalcitonin level was left to the
attending physicians, the data for procalcitonin were
obtained only from 63 (61%) of 103 patients, thereby
yielding relatively lower discriminative power (AUC
0.65 [95% CI, 0.54-0.77], data not shown) compared to
the previous reports [28]. More studies with large
number of patients are required to validate the clinical
usefulness of DNI as a severity and prediction marker
of sepsis. Further studies are also warranted to investi-
gate the additional benefit of combining DNI with
other biomarkers, such as procalcitonin, to improve
their predictive power.
Conclusion
The present study demonstrated that DNI, which
reflects the proportion of immature granulocytes in cir-
culating blood, correlates with disease severity of sepsis
in critically ill patients admitted to the medical ICU. For
assessing the risk of severe sepsis/septic shock, DNI may
be a better predictive marker than other leukocyte-
derived parameters. The elevation of DNI value may
help to identify patients with possible co-existent DIC
and patients with an imminent risk of developing severe
sepsis/septic shock. Thus, incorporating the immature
granulocyte assay into the routine algorithms may
improve the early detection of severe sepsis/septic
shock.
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